Food and Drug Administration v. Alliance for Hippocratic Medicine
602 U.S. 367 · U.S. Supreme Court
Holding and boundaries
Held that the plaintiff organizations and doctors lacked Article III standing to challenge FDA actions concerning mifepristone.
Scope and limitations: Did not decide the merits, safety or legality of FDA's regulatory decisions; it is authority about standing and access to court.
0 issue placements
Publication and provenance
The authority is published once; issue-specific orientation and fit remain separate placements. Analogue, contextual, and historical-adverse fits are not represented as controlling.
Published under research-publication-clearance-2026-07-21. deterministic validation and objective verification are not claimed.